ES2166278A1 - Procedimiento de preparacion de polvos nasales por atomizacion utilizando excipientes insolubles y absorbentes como promotores de absorcion nasal. - Google Patents

Procedimiento de preparacion de polvos nasales por atomizacion utilizando excipientes insolubles y absorbentes como promotores de absorcion nasal.

Info

Publication number
ES2166278A1
ES2166278A1 ES009902043A ES9902043A ES2166278A1 ES 2166278 A1 ES2166278 A1 ES 2166278A1 ES 009902043 A ES009902043 A ES 009902043A ES 9902043 A ES9902043 A ES 9902043A ES 2166278 A1 ES2166278 A1 ES 2166278A1
Authority
ES
Spain
Prior art keywords
drug
nasal
insoluble
atomization
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009902043A
Other languages
English (en)
Other versions
ES2166278B2 (es
Inventor
Duran Santiago Torrado
Duran Juan Jose Torrado
Arieta Alfredo Garcia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Complutense de Madrid
Original Assignee
Universidad Complutense de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Complutense de Madrid filed Critical Universidad Complutense de Madrid
Priority to ES9902043A priority Critical patent/ES2166278B2/es
Priority to PCT/ES2000/000346 priority patent/WO2001019344A1/es
Priority to AU74229/00A priority patent/AU7422900A/en
Publication of ES2166278A1 publication Critical patent/ES2166278A1/es
Application granted granted Critical
Publication of ES2166278B2 publication Critical patent/ES2166278B2/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento de preparación de polvos nasales por atomización utilizando excipientes insolubles y absorbentes como promotores de absorción nasal. Procedimiento de atomización que consiste en adicionar el fármaco en solución sobre el excipiente, que debe ser insoluble en el medio de dispersión y en el solvente de la solución de fármaco y capaz de absorber el volumen de la solución de fármaco que se le adicione. Este excipiente hidratado y cargado con fármaco se dispersará en un medio de atomización que puede ser de dos tipos. 1. Medio en el que el fármaco sea insoluble e inmiscible con el solvente de la solución de fármaco, para evitar que el fármaco escape al medio de dispersión. 2. Medio que no cumpla las características anteriores pero al que se adiciona el excipiente hidratado y cargado con fármaco justo antes de la nebulización para que no dé tiempo a que el fármaco se escape.
ES9902043A 1999-09-14 1999-09-14 Procedimiento de preparacion de polvos nasales por atomizacion utilizando excipientes insolubles y absorbentes como promotores de absorcion nasal. Expired - Fee Related ES2166278B2 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES9902043A ES2166278B2 (es) 1999-09-14 1999-09-14 Procedimiento de preparacion de polvos nasales por atomizacion utilizando excipientes insolubles y absorbentes como promotores de absorcion nasal.
PCT/ES2000/000346 WO2001019344A1 (es) 1999-09-14 2000-09-14 Procedimiento de preparacion de polvos nasales por atomizacion utilizando excipientes insolubles y absorbentes como promotores de absorcion nasal
AU74229/00A AU7422900A (en) 1999-09-14 2000-09-14 Method for the preparation of nasal powders by atomization using insoluble and absorbing excipients as nasal absorption promoters

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9902043A ES2166278B2 (es) 1999-09-14 1999-09-14 Procedimiento de preparacion de polvos nasales por atomizacion utilizando excipientes insolubles y absorbentes como promotores de absorcion nasal.

Publications (2)

Publication Number Publication Date
ES2166278A1 true ES2166278A1 (es) 2002-04-01
ES2166278B2 ES2166278B2 (es) 2003-06-16

Family

ID=8309931

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9902043A Expired - Fee Related ES2166278B2 (es) 1999-09-14 1999-09-14 Procedimiento de preparacion de polvos nasales por atomizacion utilizando excipientes insolubles y absorbentes como promotores de absorcion nasal.

Country Status (3)

Country Link
AU (1) AU7422900A (es)
ES (1) ES2166278B2 (es)
WO (1) WO2001019344A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576224B1 (en) 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
CA2575706A1 (en) * 2004-08-02 2006-02-23 Bebaas, Inc. Vitamin b12 compositions
US20130131007A1 (en) 2005-09-07 2013-05-23 Bebaas, Inc. Vitamin b12 compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0490806A2 (en) * 1990-09-20 1992-06-17 Sandoz Ltd. Nasal pharmaceutical compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0490806A2 (en) * 1990-09-20 1992-06-17 Sandoz Ltd. Nasal pharmaceutical compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CONTE, U. et al. Spray-dried albumin microspheres containing nicardipine. Eur. J. Pharm. Biopharm., (1994), 40 (4), 203-8. *
VIDGREN, P. et al. In vitro and in vivo evaluation of nasal mucoadhesion of disodium cromoglycate microspheres. Proc. Program. Int. Symp. Controlled Release Bioact. Mater., 18th, (1991), 638-9. Editor(s): Kellaway, Ian W. Publisher: Controlled Release Soc., Deerfield, IL. *

Also Published As

Publication number Publication date
AU7422900A (en) 2001-04-17
WO2001019344A1 (es) 2001-03-22
ES2166278B2 (es) 2003-06-16

Similar Documents

Publication Publication Date Title
EA199900201A1 (ru) Фармацевтическая аэрозольная композиция
MXPA04004730A (es) Composiciones farmaceuticas en forma particulada.
AU6514398A (en) Absorbent members for body fluids using hydrogel-forming absorbent polymer
BR9909394A (pt) Composição de aerossol, composição farmacêutica, recipiente, dispositivo de inalação, processo para preparar uma composição de aerossol, mistura de um primeiro material particulado, e, processo para administrar um medicamento particulado
DK0710113T3 (da) Præparat til forbedring af blodforsyning indeholdende magnetisk hårde partikler
DK0706382T3 (da) Terapeutisk præparat til inhalation
JPS5213539A (en) Preparation of aqueous dispersion of polyolefin composition
ATE161174T1 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
BRPI0414051A (pt) partìculas de resina absorvente e absorvente e partìcula absorvente empregando a mesma
DE59610369D1 (de) Verfahren zur Herstellung von in wässrigem Medium redispergierbaren Polymerisatpulvern
AU6611898A (en) Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer
ES2166278A1 (es) Procedimiento de preparacion de polvos nasales por atomizacion utilizando excipientes insolubles y absorbentes como promotores de absorcion nasal.
NZ237513A (en) Retinoic acid esters, preparation and pharmaceutical/cosmetic compositions thereof
ATE130770T1 (de) Einrichtung zur inhalation eines medikaments.
JPS52125630A (en) Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS54119585A (en) Production of polymer composition containing physiologically active substance
AR011100A1 (es) Adn obtenible de s. clavuligerus, vector que comprende dicho adn, organismo hospedador, s. clavuligerus, procedimiento para mejorar la produccion de5r-clavam en un microorganismo adecuado, microorganismo que tiene las facultades para la produccion de 5r-clavam y una produccion baja o nula de 5s-
BR0015422A (pt) Formulações de droga de liberação prolongada
ES2082523T3 (es) Un medicamento de accion retardada que contiene ibuprofen y su empleo.
CN208552091U (zh) 一种设有固定板的移动式牙科治疗机
JPS5518206A (en) Spraying apparatus
PL1518551T3 (pl) Stała postać dawki zawierająca kofeinę
KR920019355A (ko) 불안증 치료용 상승작용성 혼합물
DE69333266D1 (de) Zusammensetzung zur verminderung von nebenwirkungen eines arzneimittels

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20020401

Kind code of ref document: A1

Effective date: 20020401

FG2A Definitive protection

Ref document number: 2166278B2

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20191230